A prospective study on epidermal growth factor receptor mutations in non-small cell lung cancer in Malaysian patients
| Main Authors: | Liam, C K, Leow, HR, How, Soon Hin, Pang, YK, Chua, K T, Lai, NL, Lim, BK, Lee, CH, Kuan, Yeh Chunn, Jayalakshimi, P, Pathmanathan, R. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-Blackwell
2012
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/29823/ http://irep.iium.edu.my/29823/1/IMG.pdf |
Similar Items
Epidermal growth factor receptor (EGFR) mutations are the main oncogenic driver mutation in adenocarcinoma in never-smokers - findings from the emlan study
by: Liam, Chong Kin, et al.
Published: (2012)
by: Liam, Chong Kin, et al.
Published: (2012)
Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic Malaysian patient population
by: Liam, Chong-Kin, et al.
Published: (2014)
by: Liam, Chong-Kin, et al.
Published: (2014)
Epidermal Growth Factor Receptor Mutation in Newly
Diagnosed Lung Adenocarcinoma
by: Chee, Shee Chai, et al.
Published: (2017)
by: Chee, Shee Chai, et al.
Published: (2017)
Detection of epidermal growth factor receptor mutations in formalin fixed paraffin embedded biopsies in Malaysian non-small cell lung cancer patients
by: Ng, Tiffany Shi Yeen, et al.
Published: (2013)
by: Ng, Tiffany Shi Yeen, et al.
Published: (2013)
Epidermal growth factor receptormutations in lung adenocarcinoma in Malaysian patients
by: Liam, Chong Kin, et al.
Published: (2013)
by: Liam, Chong Kin, et al.
Published: (2013)
Case Series of Small Cell Lung Cancer Transformation
as Resistance Mechanism to Epidermal Growth Factor
Receptor-Tyrosine Kinase Inhibitor
by: Liam, C, et al.
Published: (2017)
by: Liam, C, et al.
Published: (2017)
Lung cancer in Pahang Malaysia
by: Ng, Teck Han, et al.
Published: (2009)
by: Ng, Teck Han, et al.
Published: (2009)
Treatment compliance among lung cancer patient in Malaysia
by: Ng, Teck Han, et al.
Published: (2008)
by: Ng, Teck Han, et al.
Published: (2008)
Treatment compliance among lung cancer patient in Malaysia
by: Ng, Teck Han, et al.
Published: (2008)
by: Ng, Teck Han, et al.
Published: (2008)
Resistance mechanisms causing first-line epidermal growth factor receptor-tyrosine kinase inhibitor treatment failure
by: Chai, C.S., et al.
Published: (2017)
by: Chai, C.S., et al.
Published: (2017)
Defaulters among lung cancer patients in a suburban district in a developing country
by: Ng, Teck Han, et al.
Published: (2012)
by: Ng, Teck Han, et al.
Published: (2012)
Survival of lung cancer patients in a resource-limited country
by: How, Soon Hin, et al.
Published: (2015)
by: How, Soon Hin, et al.
Published: (2015)
Case report: a bleeding abscess-massive massive Haemoptysis from a Lung abcess
by: Ng, Teck Han, et al.
Published: (2008)
by: Ng, Teck Han, et al.
Published: (2008)
Characteristics of epidermal growth factor receptor (EGFR)-Mutated Non Small Cell Lung Carcinoma (NSCLC)-patients who developed resistance to first or second generation Egfrtyrosine Kinase Inhibitor (TKI) Therapy through T790M mutation / Vijayan Munusamy
by: Vijayan, Munusamy
Published: (2017)
by: Vijayan, Munusamy
Published: (2017)
Targeting the hypoxic expression of epidermal growth factor receptor
by: Alamoudi, Abdulmohsin
Published: (2021)
by: Alamoudi, Abdulmohsin
Published: (2021)
Lung cancer in Malaysia
by: Rajadurai, Pathmanathan, et al.
Published: (2020)
by: Rajadurai, Pathmanathan, et al.
Published: (2020)
Survival analysis among lung cancer patients in Pahang
by: Ng, Teck Han, et al.
Published: (2010)
by: Ng, Teck Han, et al.
Published: (2010)
Translational control of epidermal growth factor receptor in neurodegenerative diseases
by: Smalley, Daniel. S.
Published: (2017)
by: Smalley, Daniel. S.
Published: (2017)
Asthma control in Hospital Tengku Ampuan Afzan, Kuantan, Malaysia: a cross-sectional study
by: Kuan, Yeh Chunn, et al.
Published: (2015)
by: Kuan, Yeh Chunn, et al.
Published: (2015)
Outcome of patients with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor tyrosine kinase inhibitors versus cytotoxic chemotherapy
by: Chai, Chee She
Published: (2015)
by: Chai, Chee She
Published: (2015)
Small Cell Transformation and T790M Mutation as
Coresistance Mechanisms for First-line Epidermal
Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy Failure
by: Chee, Shee Chai
Published: (2017)
by: Chee, Shee Chai
Published: (2017)
Detection of Isocitrate Dehydrogenase (IDH-1), Epidermal Growth Factor Receptor (EGFR), P53 and C-erbB2/HER2 mutation in glial tumour
by: Azman, Nusaibah, et al.
Published: (2022)
by: Azman, Nusaibah, et al.
Published: (2022)
Biological significance of human epidermal growth factor receptor 2 (HER2) in breast cancer: effect of oestrogen receptor
by: Ahmad, Dena Akram Jerjees
Published: (2016)
by: Ahmad, Dena Akram Jerjees
Published: (2016)
Mutational profiling of lung cancer using next generation sequencing: a Malaysian real-world clinical diagnostic experience
by: Rajadurai, Pathmanathan, et al.
Published: (2023)
by: Rajadurai, Pathmanathan, et al.
Published: (2023)
The “crazy paving pattern” lung in a pregnant woman
by: Mohd Firdaus, Mohd Al-Baqlish, et al.
Published: (2015)
by: Mohd Firdaus, Mohd Al-Baqlish, et al.
Published: (2015)
Diffuse panbronchiolitis mimicking miliary pulmonary tuberculosis
by: Abdul Azih, Muhammad Naimmuddin, et al.
Published: (2013)
by: Abdul Azih, Muhammad Naimmuddin, et al.
Published: (2013)
An investigation into the effects of the epidermal growth factor receptor tyrosine kinase inhibitor "Gefitinib" on human breast cancer
by: Gutteridge, Eleanor
Published: (2010)
by: Gutteridge, Eleanor
Published: (2010)
The bug and the big heart -- Melioidotic pericardial effusion
by: Kuan, Leong Yew, et al.
Published: (2011)
by: Kuan, Leong Yew, et al.
Published: (2011)
An internal ribosome entry site in the 5′ untranslated region of epidermal growth factor receptor allows hypoxic expression
by: Webb, Thomas E., et al.
Published: (2015)
by: Webb, Thomas E., et al.
Published: (2015)
Anti-tumor activity of metformin in human epidermal growth factor receptor 2 positive breast cancer cells
by: Huda, Fathul, et al.
Published: (2021)
by: Huda, Fathul, et al.
Published: (2021)
Bone mineral density in patients with bronchial asthma on inhaled corticosteroids
by: Kuan, Yeh Chunn, et al.
Published: (2008)
by: Kuan, Yeh Chunn, et al.
Published: (2008)
Airway Y-stent Insertion in Tracheobronchomalacia: A New Experience
by: Kuan, Yeh Chunn, et al.
Published: (2012)
by: Kuan, Yeh Chunn, et al.
Published: (2012)
Exploring the potential of biologically active phenolic acids from marine natural products as anticancer agents targeting the epidermal growth factor receptor
by: Roney, Miah, et al.
Published: (2023)
by: Roney, Miah, et al.
Published: (2023)
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
by: Wu, Y-L, et al.
Published: (2015)
by: Wu, Y-L, et al.
Published: (2015)
Dealing with lung cancer complications: how aggressive can we be?
by: How, Soon Hin
Published: (2013)
by: How, Soon Hin
Published: (2013)
Monitoring treatment response in sputum smear positive pulmonary tuberculosis patients: Comparison of weight gain, sputum conversion and chest radiograph
by: How, Soon Hin, et al.
Published: (2014)
by: How, Soon Hin, et al.
Published: (2014)
A case report of airway stenting in tracheal compression secondary to right subclavian artery pseudo-aneurysm
by: Abdul Azih, Muhammad Naimmuddin, et al.
Published: (2018)
by: Abdul Azih, Muhammad Naimmuddin, et al.
Published: (2018)
Asthma control in HTAA, Kuantan: a cross sectional study
by: Kuan, Yeh Chunn, et al.
Published: (2012)
by: Kuan, Yeh Chunn, et al.
Published: (2012)
Dermal contributions to human interfollicular epidermal architecture and self-renewal
by: Lawlor, K., et al.
Published: (2015)
by: Lawlor, K., et al.
Published: (2015)
Mapping 18F-fluorodeoxyglucose metabolism using PET/CT for the assessment of treatment response in non-small cell lung cancer patients undergoing epidermal growth factor receptor inhibitor treatment: a single-centre experience
by: Suppiah, Subapriya, et al.
Published: (2017)
by: Suppiah, Subapriya, et al.
Published: (2017)
Similar Items
-
Epidermal growth factor receptor (EGFR) mutations are the main oncogenic driver mutation in adenocarcinoma in never-smokers - findings from the emlan study
by: Liam, Chong Kin, et al.
Published: (2012) -
Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic Malaysian patient population
by: Liam, Chong-Kin, et al.
Published: (2014) -
Epidermal Growth Factor Receptor Mutation in Newly
Diagnosed Lung Adenocarcinoma
by: Chee, Shee Chai, et al.
Published: (2017) -
Detection of epidermal growth factor receptor mutations in formalin fixed paraffin embedded biopsies in Malaysian non-small cell lung cancer patients
by: Ng, Tiffany Shi Yeen, et al.
Published: (2013) -
Epidermal growth factor receptormutations in lung adenocarcinoma in Malaysian patients
by: Liam, Chong Kin, et al.
Published: (2013)